Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Been here since the 30p’s and in my experience ‘SNG are as silent as the grave’ when it comes to leaking info of any kind. I respect them for that. When they have something to say they say it. Investors see through companies who keep releasing RNS’s to announce a trip to the latrine.
Likewise Andy- none of us have control. We are but twigs flowing on the river of a mighty stream.:). Patience seems to weed out the people that make money and the people who don’t. Just a waiting game now GLA.
Thank you DG i must have lost a day somewhere.:)
SIDM- You can indeed, please make your cheque payable to Miggy007 address- Lagos, Nigeria.
Alternatively Deloreans were made in Ireland but alas firm went bankrupt so you would have to literally go 'back to the future'. Please just drive your Nissan at 88mph whilst running an electric cable from your local clock tower to an overhead electric pylon. You'll be fine .
The way i understand it over here is that (and the CEO backed this up talking to Katie at Proactive) you had to purchase TILS shares by COB on Wednesday (yesterday) because it works on the T+2 settlement, thus your name must be on the register by 7am Friday 30/10/20, to be eligible for Accustem free shares. If you bought today or tomorrow you won't be registered on the record for 7am Friday so you will miss out i'm afraid. At least thats what the CEO said! so if i'm wrong he's wrong!!:)
I suspect its a great buying day across the board. SNG, NYCT and Orphen along with everything else pretty much all down heavily on no news. All those having COVID action shouldnt really be down as much imo. Not exactly going away is it. i was happy buying at 175p so you have to be happy sub 170p if you have funds to buy in. The drug doesnt know the share price has fluctuated.
Really good find Oxford. It appears to mirror the home trial somewhat which we have already setup and hopefully progressing along the road with. I’m not entirely certain whether SNG would be the right company to provide the service which I believe the NHS are looking for here? The drug clearly is what they need and there own definition of interventions which they see as ideal are described as ‘drugs or antibodies with a good side effect profile delivered through regular administration via an easily achievable and acceptable route’. That describes SNG to a tee really. ‘Cost effectiveness is a secondary outcome’ is also of interest. I wouldn’t take any of the 2/5 though. Odds are my thing and the fact this government hasn’t aided us so far in the home trials and is willing to vote on kids going hungry isn’t a government I would place a great deal of faith in to make the right choices. Let’s hope I’m wrong but I still think the home trial can be wrapped up quicker in all probability.
Bought in at 174p today thinking it was an ok entry point but now not so sure given the RNS? I read it as deadline of 9pm tomorrow our time Which is 5pm EDT. Is this not the deadline to qualify for accustem shares?
Thinking SNG can be kicked into the long grass until a vaccine comes along is a mistake. You can’t keep a good product down and the entire world would have to be complicit which I believe is impossible. Vaccines even if they are proven will not become the silver bullet. Their will always be the need for successful therapeutics and SNG looks a good bet to be effective against future respiratory disorders too.
Comparing vaccines to SNG or any therapeutic is a moot point really. Both vaccine and cure are desperately needed. Having an effective vaccine will not mean we won’t need SNG. A vaccines efficacy if we are very lucky will be 50-60%. Like the current flu jabs which are created from egg culture the efficacy over the last ten years ranges from around 20%-50% per any flu season. Certain cohorts will not be eligible for the vaccine. Certain elder groups and babies under six months can’t be given the flu jab. The team at Synairgen know this and know they will have a huge role to play in the battle against the virus for years to come. This virus is too contagious and hides itself too well for it to peter out I’m afraid. It will be with us for the foreseeable.
I started watching the ‘hot Zone’ not a babe station production but based somewhat on the Robert Preston book about Ebola Virus (which I read years ago and is a great book) and how a form of it ended up in Reston, Virginia at a monkey processing facility. Prophetically it ended up summarising that the Earths biggest pathogens are humans. The Earths immune system is protecting itself by unleashing these viruses when humans destroy and disturb creatures habitats, particularly the prime hosts such as bats etc. Trying to look at the bigger picture it strikes me that COVID-19 is just one of a number of viruses that has hit us as a result of mans greed. If we carry on down that road then more viruses, respiratory and otherwise will emerge from the less explored corners of the world. Applying this to SNG I believe means, sadly, that it may be required into the foreseeable future, not just to tackle COVID-19. We do really need to change course though don’t we.
Reading some worrying news from Belgium, the Wallonia region is up to virtual full capacity in their covid wards. Doctors are facing the stark choice of making triage decisions on who gets hospital beds or not. Only has a population of 11 million Belgium and they are getting 10,000 new cases a day now. The UK is two-three weeks behind Belgium in the cycle. It is going to be incredibly frustrating here if we do see the Nightingales filling up and the Gov proves to have done too little too late in supporting us and other viable therapeutics. Tell the hospitalised this winter their is a vaccine possibly coming in the Spring.
Something else that keeps nagging me is that if RM was asking big dollars for SNG001 from big pharma, which he is entitled to do, they may have just looked at it and thought, you know what their market cap is around £280 million let’s just buy them. It’s a long shot but it is certainly possible. Nothing would surprise me.
It was pretty obvious an order was being filled tbh. MM’s make a penny a share or thereabouts, by keeping the spread tight encouraging sellers, on 2.4m shares dealt and plus their commission for the trade. No fluctuations today to attract traders. I think it’s pretty solid at this level, we’re still able to buy in lower than Venrock which is good enough for me.
Or alikened to Rocky Marciano when someone asked him 'when did you realise you could fight?'. He replied a 'fight broke out in a bar full of lumberjacks (his occupation for a while) and their were ten people left standing, then two people, then just him'. At the moment SNG001 is the only one standing with a high degree of efficacy. Everything else is smoke and mirrors until proof emerges.
But how many showed high efficacy at Phase II trial, and how many are fully funded and about to commence Phase III. That should whittle the list down somewhat Org. Going back to what RM said months ago. Data is king. Therapeutics and Vaccines will be announced aplenty but how many will be left standing. Thats all that matters.
Nearly accosted someone who looked like Dominic Raab walking around Elmbridge area M&S. I was going to breach his privacy and ask him has he heard of SNG001 and why is the government not doing more to help. Good job i didnt as it wasn't him. As the area he represents is now on the high tier alert you'd think someone would light a bonfire under their asses to get this done, as Boris would say.